Neurologic Aspects of Systemic Disease, Part I

Handbook of Clinical Neurology (Series Editors: Aminoff, Boller and Swaab)
 
 
Elsevier (Verlag)
  • 1. Auflage
  • |
  • erschienen am 9. Januar 2014
  • |
  • 760 Seiten
 
E-Book | ePUB mit Adobe DRM | Systemvoraussetzungen
978-0-7020-4432-8 (ISBN)
 

Systemic disease involves several parts of the body or the complete system. Neurologic Aspects of Systemic Disease, a two-part volume in the Handbook of Clinical Neurology series, focuses on the specific neurologic aspects of systemic disease.

Part 1 includes detailed coverage of cardiovascular disease, pulmonary diseases, renal diseases, and rheumatologic and musculoskeletal disease. Each chapter provides a complete introduction to the neurologic aspect and provides best known diagnostic and treatment practices. The collection is a valuable and trusted resource for clinical neurologists, research neurologists, neuroscientists, and general medical professionals; a first stop for a focused review of the state of the art for understanding the neurologic impact of each covered disease.


  • A comprehensive introduction and overview of the neurologic aspects of systemic disease
  • Part 1 covers cardiovascular disease, pulmonary diseases, renal diseases and rheumatologic/musculoskeletal disease
  • Each chapter focuses on the neurologic aspects related to a specific disease presentation
0072-9752
  • Englisch
  • Amsterdam
  • |
  • Niederlande
Elsevier Science
  • 37,97 MB
978-0-7020-4432-8 (9780702044328)
0702044326 (0702044326)
weitere Ausgaben werden ermittelt
  • Front Cover
  • Neurologic Aspects of Systemic Disease Part I
  • Coyright
  • Handbook of Clinical Neurology 3rd Series
  • Foreword
  • Preface
  • Contributors
  • Contents of Part I
  • Contents of Part II
  • Contents of Part III
  • Section 1: Neurologic Aspects of Cardiovascular Disease
  • Chapter 1: Cardiovascular Manifestations of Neurologic Disease
  • Cardiology in Vascular and Intensive Care Neurology
  • Pathophysiology
  • Acute Ischemic Stroke
  • Intraparenchymal Hemorrhage
  • Subarachnoid Hemorrhage
  • Head Trauma
  • Management of Neurogenic Cardiac Events
  • Cardiology of Paroxysmal Neurologic Events
  • Migraine
  • Epilepsy
  • Cardiology of Movement Disorders and Neurodegenerative Diseases
  • Parkinson Disease and Parkinsonian Disorders
  • Dementia
  • Degenerative Ataxias: Friedreichs Ataxia
  • Neuromuscular Disorders with Cardiac Manifestations
  • Disorders of Peripheral Nerves
  • Guillain-Barré Syndrome
  • Diabetic Cardiac Autonomic Neuropathy
  • Disorders of Neuromuscular Junction
  • Disorders of Muscle
  • Dystrophinopathies
  • Emery-Dreyfus Muscular Dystrophy
  • Myotonic Dystrophy
  • Mitochondrial Cytopathies
  • Conclusion
  • Chapter 2: Sudden Cardiac Death
  • Introduction
  • History
  • Definition
  • Pathophysiology and Histopathology
  • Precipitants
  • Clinical Manifestations
  • Electrical Conduction Abnormalities
  • Stress Cardiomyopathy
  • Specific Clinical Scenarios
  • Sudden Unexplained Death in Epilepsy
  • Sudden Death After Stroke
  • Potential Preventive Strategies
  • Chapter 3: Neurologic Complications of Cardiac Arrest
  • Neurologic Complications of cardiac Arrest
  • Epidemiology of Cardiac Arrest
  • In-hospital Cardiac Arrest
  • Out-of-hospital Cardiac Arrest
  • Treatment of Cardiac Arrest
  • Basic Measures
  • Therapeutic Hypothermia for Cardiac Arrest
  • Sedation and Neuromuscular Blockade
  • Seizure Control and Prevention
  • Neuroprotective Pharmacology
  • Prognosis
  • Long-term Complications of cardiac Arrest
  • Conclusion
  • Chapter 4:Neurologic Complications of Cardiac Tests and Procedures
  • History
  • Clinical Manifestations of Neurologic Complications of Cardiac Tests and Procedures
  • Peripheral Nervous System (PNS) Complications
  • Pns Complications of Radial Artery Catheterization
  • Pns Complications of Brachial Artery Catheterization
  • Pns Complications of Axillary Artery Catheterization
  • Pns Complications of Femoral Artery Catheterization
  • Pns Complications of Central Venous Catheterization
  • Pns Complications of Transesophageal Echocardiography
  • Central Nervous System (CNS) Complications
  • Cns Complications of Cardiac Catheterization
  • Cerebral Embolism and Ischemic Stroke
  • Transient Cortical Blindness Following Cardiac Catheterization
  • Cns Complications of Central Venous Access catheters
  • Cns Complications of Thrombolysis for Acute Myocardial Infarction
  • Laboratory Investigations
  • Management of Acute Stroke in the Cardiac Intensive Care Unit
  • Conclusions, Future Directions
  • Chapter 5: Neurologic Complications of Congenital Heart Disease and its treatment
  • History of Congenital Heart disease
  • Incidence of Congenital Heart disease
  • Signs and Symptoms of Congenital Heart Disease
  • Cerebrovascular Complications of Congenital Heart Disease
  • Infective Embolism From Congenital Heart Disease
  • Cognitive Disturbances with Congenital Cardiac Disease
  • Brain Anomalies with Congenital Heart Disease
  • Cerebral Aneurysm and Aortic Coarctation
  • Complications of Management
  • Laboratory Investigations
  • Management
  • Conclusion
  • Chapter 5: Neurologic Complications of Valvular Heart Disease
  • Introduction
  • Rheumatic Valvular Heart Disease
  • Calcific Valve Disease
  • Aortic Stenosis
  • Mitral Annulus Calcification
  • Mitral Valve Prolapse
  • Prosthetic Heart Valves
  • Bioprosthetic Heart Valves
  • Aortic Bioprosthetic Valves
  • Mitral Bioprosthetic Valves
  • Mechanical Heart Valves
  • Anticoagulation and Its Complications
  • Emergent Use of Anticoagulation During Acute Ischemic Stroke
  • Infective Endocarditis
  • Cerebrovascular Complications
  • Ischemic Stroke
  • Risk Factors for Embolism
  • Intracranial Hemorrhage
  • Mycotic Aneurysm
  • Noncerebrovascular Complications
  • Infection
  • Meningitis
  • Abscess
  • Encephalopathy
  • Seizures
  • Cardiac Surgery
  • Antithrombotic Therapy in Infective Endocarditis
  • Noninfective Endocarditis
  • Marantic Endocarditis
  • Libman-Sacks Endocarditis
  • Chapter 7: Infective Endocarditis
  • Definition
  • Classification
  • Historical Aspects
  • Epidemiology
  • Pathophysiology
  • Clinical Aspects
  • Systemic, Cardiac and Multiorgan Manifestations
  • Neurologic Manifestations
  • Cerebrovascular Complications
  • Ischemic Stroke
  • Intracranial Hemorrhage
  • Mycotic Aneurysms
  • Central Nervous System Infection
  • Other Neurologic Manifestations
  • Acute Encephalopathy
  • Mononeuropathy and Polyneuropathy
  • Diagnosis
  • Laboratory
  • Electrocardiography
  • Echocardiography
  • Identification of the Pathogenic Agent
  • Diagnostic Criteria
  • Diagnosis of the Neurologic Complications
  • Prognosis
  • Prevention
  • Treatment
  • Antimicrobial Therapy
  • Role of Cardiac Surgery
  • Treatment of Endocarditis Associated with cardiovascular Implantable Electronic devices
  • Treatment of the Neurologic Complications
  • Thrombolysis in Acute Stroke Associated with endocarditis
  • Antithrombotic Treatment
  • Cardiac Surgery After a Neurologic Complication
  • Treatment of Mycotic Aneurysms
  • Treatment of Intracranial Infections
  • Conclusions
  • Chapter 8: Neurologic Complications of Myocardial Infarction
  • History
  • Epidemiology
  • Risk Factors
  • Etiology
  • Clinical Findings, Clinical Presentation, and Diagnostic Criteria
  • Laboratory Investigations
  • Neuroimaging Investigations
  • Mri Issues at 3 Tesla and Coronary Artery stents
  • Pathology
  • Management
  • Antiplatelet Therapy and Acute Coronary syndrome
  • Classification of Antiplatelet Agents
  • Anticoagulation and Acute Coronary syndrome
  • Thrombolytic Agents
  • Management of Intracerebral Hemorrhage After Thrombolysis for Acute Coronary syndrome
  • Prevention
  • Prognosis
  • Conclusion and Future Directions
  • Chapter 9: Neurologic Complications of Cardiomyopathies and other myocardial Disorders
  • Introduction
  • Patent Foramen Ovale
  • Left Ventricular Dysfunction
  • Takotsubo Stress Cardiomyopathy
  • Atrial Fibrillation
  • Risk Stratification Schemes
  • Bleeding Risk: Warfarin Usage in Patients with Atrial Fibrillation
  • Genetics
  • Mitochondrial Dysfunction
  • Summary
  • Chapter 10: Neurologic Complications of Arrhythmia Treatment
  • Direct Neurologic Complications of Arrhythmia
  • Stroke and Cerebrovascular Disease
  • Atrial Fibrillation
  • Sick Sinus Syndrome
  • Multifocal Premature Ventricular Contractions
  • Supraventricular Tachycardia
  • Wolff-Parkinson-White Syndrome
  • Disorders of Cognition
  • Cognitive Impairment
  • Dementia
  • Neurologic Complications of arrhythmia Treatment: Cardiopulmonary Resuscitation
  • Neurologic Complications of Arrhythmia Treatment: Drugs
  • Antiarrhythmics
  • Hematologic Agents
  • Direct Thrombin Inhibitors
  • Neurologic Complications of Arrhythmia Treatment: Cardiology Procedures
  • Electrical Cardioversion
  • External Cardioversion
  • Internal Cardioversion
  • Pacemakers
  • Bradycardia
  • Sinus Node Dysfunction
  • Sick Sinus Syndrome
  • Implantable Defibrillators
  • Electrophysiologic Procedures
  • Stroke
  • Phrenic Nerve Injury
  • Percutaneous Closure of the Left Atrial appendage
  • Neurologic Complications of Arrhythmia Treatment: Cardiovascular Surgery
  • The Maze Procedure
  • Epicardial Radiofrequency Atrial And/or Pulmonary Vein Isolation and Ganglionated Plexus Ablation
  • Other Cardiac Surgical Procedures
  • Conclusion
  • Chapter 11: Neurologic Complications of Catheter Ablation/defibrillators/pacemakers
  • Introduction
  • History
  • Clinical History
  • Thromboembolism Associated with Ablation of Atrial Fibrillation
  • Thromboembolism Associated with Catheter Ablation of Other Supraventricular and Ventricular Arrhythmias
  • Cerebral Air Embolism Complicating Catheter ablation Procedures
  • Phrenic Nerve Injury During Catheter Ablation
  • Natural History
  • Thromboembolism During Catheter Ablation
  • Cerebral Air Embolism
  • Laboratory Investigations
  • Catheter Ablation of Atrial Fibrillation
  • Cerebral Air Embolism
  • Neuroimaging Investigations
  • Thromboembolism During Catheter Ablation
  • Genetics
  • Pathology
  • Management
  • Thromboembolism During Catheter Ablation
  • Cerebral Air Embolus
  • Neurologic Complications Associated with Pacemakers and Defibrillators
  • Conclusion
  • Chapter 12: Hypertension and Hypertensive Encephalopathy
  • History and Terminology
  • Clinical Findings
  • Natural History
  • Laboratory Investigations
  • Neuroimaging Investigations
  • Genetics
  • Pathology
  • Management
  • Conclusions
  • Chapter 13: Transient Loss of Consciousness and Syncope
  • Introduction: Definitions, Nomenclature, and Classification
  • Epidemiology of Transient Loss of Consciousness/syncope
  • Causes of Transient Loss of Consciousness
  • Syncopal Transient Loss of Consciousness Due to Cerebral Hypoperfusion
  • Cardiac Syncope
  • Clinical Features
  • Pathophysiology
  • Etiology
  • Orthostatic/postural Hypotension
  • Clinical Features
  • Pathophysiology
  • Etiology
  • Neurally Mediated (reflex) Syncope
  • Clinical Features
  • Pathophysiology
  • Etiologies
  • Neurologic Causes of Syncope
  • Nonsyncopal Transient Loss of Consciousness (unrelated to Cerebral Hypoperfusion)
  • Epileptic Transient Loss of Consciousness
  • Clinical Features
  • Pathophysiology
  • Nonepileptic, Neurologic Causes of Transient Loss of Consciousness
  • Medical Causes of Transient Loss of consciousness
  • Psychiatric Causes of Transient Loss of Consciousness (``psychogenic Nonepileptic Seizures´´, ``psychogenic Pse...
  • Clinical Features
  • Pathophysiology/etiology
  • Traumatic Transient Loss of Consciousness
  • Differential Diagnosis of Transient Loss of Consciousness
  • Episodes Without (or with Only Apparent) Unconsciousness and Altered Postural Control (``drop Attacks´´)
  • Vertebrobasilar Transient Ischemic Attacks
  • Vestibular Syncope
  • Falls in the Context of Epilepsy Without Loss of consciousness
  • Chalastic Attacks
  • Hyperekplexia
  • Cataplexy and cataplexy-like Episodes
  • Cryptogenetic Drop Attacks in Women
  • Astasia (with and Without Abasia)
  • Falls in the Context of Gait Ataxia and Extrapyramidal Disorders
  • Falls in the Context of Muscle Weakness
  • Psychiatric Disorders (``psychogenic Falls´´)
  • Accidental Falls
  • Episodes of Altered State of Consciousness Without Loss of Postural Control (``absences´´/``absent Mindedness&r...
  • Sleepiness/``sleep Attacks´´
  • Other Forms of Fluctuating Vigilance
  • Epilepsy
  • Metabolic/neuroendocrine Disorders
  • Psychiatric Disorders
  • Others/unclear
  • Diagnostic Workup of Transient Loss of Consciousness
  • Clinical History
  • Physical Examination
  • Basic Investigations
  • Further Investigations
  • Prolonged Ecg Monitoring
  • Echocardiography
  • Head-up Tilt Test
  • Carotid Sinus Massage
  • Others
  • Treatment of Transient Loss of Consciousness
  • Treatment of Syncopal Transient Loss of Consciousness
  • Cardiac Syncope
  • Orthostatic Syncope
  • Neurally Mediated Syncope
  • Treatment of Nonsyncopal Transient Loss of consciousness
  • Driving in Patients with Transient Loss of consciousness
  • Acknowledgments
  • Chapter 14: Neurologic Complications of Cardiac Surgery and interventional cardiology
  • Introduction
  • History
  • Clinical Findings
  • Cardiac Catheterization and Percutaneous Coronary Intervention
  • Coronary Artery Bypass Grafting
  • Valvular Surgery
  • Patent Foramen Ovale/atrial Septal Aneurysm surgery
  • Surgery for Cardiac Tumors
  • Mechanical Circulatory Devices
  • Pathology
  • Cardiac Catheterization and Percutaneous Coronary Intervention
  • Coronary Artery Bypass Grafting
  • Valvular Surgery
  • Patent Foramen Ovale/atrial Septal Aneurysm surgery
  • Surgery for Cardiac Tumors
  • Mechanical Circulatory Devices
  • Natural History
  • Laboratory and Neuroimaging Investigations
  • Management
  • Conclusions
  • Chapter 15: Neurologic Complications of Cardiac Tumors
  • Introduction
  • The Clinical Triad
  • Cardiac Dysfunction
  • Nonspecific Constitutional Symptoms
  • Embolic Phenomena
  • Specific Cardiac Tumors
  • Myxoma
  • Systemic Effects
  • Structural Neurologic Complications
  • Embolic Disease
  • Cerebral Aneurysms
  • Metastatic Disease
  • Other
  • Natural History
  • Pathology
  • Other Benign Primary Tumors
  • Papillary Fibroelastoma
  • Rhabdomyoma
  • Primary Malignant Cardiac Tumors
  • Secondary Tumors
  • Diagnosis
  • Echocardiography
  • Other Cardiac Imaging
  • Cerebral Imaging
  • Pathology
  • Treatment and Prognosis
  • Atrial Myxoma
  • Other Cardiac Tumors
  • Chapter 16: Neurologic Complications of Aortic Diseases and aortic surgery
  • Introduction
  • Spinal Cord Blood Supply
  • Neurologic Complications of aortic Diseases
  • Aortic Aneurysm
  • Aortic Dissection
  • Giant Cell Arteritis
  • Takayasus Arteritis
  • Aortic Coarctation
  • Syphilis Aortitis
  • Neurologic Complications with Aortic Surgery
  • Conclusion
  • Section 2: Neurologic Aspects of Pulmonary Diseases
  • Chapter 17: Breathing and the Nervous System
  • Introduction
  • Neuroanatomy of Respiratory Control
  • Cortical Control of Breathing
  • Subcortical and Brainstem Control of breathing
  • Physiologic Control of Breathing and Rhythm Generation
  • Rhythm Generation
  • Pacemaker Neurons
  • Neurochemical Control of breathing
  • Neurologic Conditions Affecting breathing
  • Diseases Affecting the Hemispheric Cortex, Subcortical Structures, and Brainstem
  • Parkinsons Disease
  • Multisystem Atrophy
  • Alzheimers Disease
  • Amyotrophic Lateral Sclerosis
  • Diseases of the Spinal Cord
  • Neuromuscular Junction Disorders and nerves
  • Clinical Manifestations of Central and Peripheral Nervous System Conditions
  • Neurogenic Pulmonary Edema
  • Chapter 18: Obstructive Sleep Apnea and Other sleep-related Syndromes
  • Obstructive Sleep Apnea
  • Definition
  • Control of Breathing During Sleep
  • Pathophysiology of Obstructive Apneas
  • Prevalence
  • Genetics
  • Pathophysiology of the Obstructive Sleep apnea Syndrome
  • Clinical Presentation
  • Neuropsychiatric Symptoms
  • Cognitive Problems
  • Depression and Obstructive Sleep Apnea syndrome
  • Imaging and Neurologic Damage in Obstructive Sleep Apnea Syndrome
  • Gender Differences
  • Risks and Predisposing Factors For obstructive Sleep Apnea
  • Diseases Associated with Obstructive Sleep Apnea Syndrome, Comorbidities
  • Clinical Observation
  • Estimating Severity
  • Assessment of Sleepiness in Obstructive Sleep apnea Syndrome
  • Diagnostic Criteria
  • Treatment
  • Positive Airway Pressure Therapy
  • Surgical Procedures
  • Oral Appliances (lower Jaw Protrusion Prostheses)
  • Pharmacologic Treatment
  • Behavior Management
  • Central Sleep Apnea and Hypoventilation Syndromes
  • Primary Central Sleep Apnea
  • Cheyne-Stokes Respiration Pattern
  • Complex Sleep Apnea Syndrome
  • High-altitude Periodic Breathing
  • Central Sleep Apnea Due to Medical Condition not Cheyne-Stokes
  • Central Sleep Apnea Due to Drug or Substance
  • Primary Sleep Apnea of Infancy
  • Sleep-related Nonobstructive Idiopathic Alveolar Hypoventilation
  • Congenital Central Alveolar Hypoventilation syndrome
  • Sleep-related Hypoventilation Due To neuromuscular and Chest Wall Disorders
  • Sleep-related Hypoventilation/hypoxemia Due to Lower Airway Obstruction
  • Sleep-related Hypoventilation Due To pulmonary Parenchymal or Vascular pathology
  • Acknowledgements
  • Chapter 19: Acute and Chronic Respiratory Failure
  • Introduction
  • General Approach to Diagnosis
  • Specific Diseases
  • Stroke
  • Amyotrophic Lateral Sclerosis
  • Guillain-Barré Syndrome
  • Cervical Spinal Cord Injury
  • Spinal Muscular Atrophy
  • Charcot-Marie-Tooth Disease
  • Duchenne Muscular Dystrophy
  • Multiple Sclerosis
  • Parkinsons Disease
  • Central Sleep Apnea
  • Critical Inflammatory Neuropathy and myopathy
  • Myasthenic Crisis
  • General Principles of Management in Respiratory Failure
  • Mechanical Ventilation
  • Volume Control Ventilation
  • Pressure Control Ventilation
  • Mechanical Ventilation in Patients with Chronic Airflow Obstruction
  • Ventilatory Strategy in Acute Respiratory Distress Syndrome
  • Complications in Mechanically ventilated Patients
  • Noninvasive Ventilation
  • Weaning From Mechanical Ventilation
  • Weaning Parameters
  • Weaning Modes and protocol-driven Weaning
  • Management of Patients on Prolonged mechanical Ventilation
  • Management of Oropharyngeal and Tracheobronchial Secretions
  • Management of Respiratory Failure in Patients with Neuromuscular Disease
  • Devices That Promote Inspiratory and Expiratory Muscle Function
  • Noninvasive Ventilation in neuromuscular Disease
  • Home Mechanical Ventilation
  • Conclusions
  • Chapter 20: Venous Thromboembolism in Neurologic Disease
  • Introduction
  • Epidemiology (with Specific Focus on Neurologic Disease)
  • General Principles
  • Presentation and Diagnosis
  • General Treatment Issues
  • Prophylaxis
  • Acute Treatment
  • Treatment Issues Specific to Neurologic and neurosurgical Disease
  • Timing of Thromboprophylaxis in Neurologic and Neurosurgical Disease
  • Venous Thromboembolism Screening in Neurologic and Neurosurgical Disease
  • Conclusions
  • Abbreviations
  • Chapter 21: Neurologic Manifestations of Sarcoidosis
  • History
  • Clinical Findings
  • Sarcoidosis
  • Neurosarcoidosis
  • Cranial Neuropathy
  • Meningeal Disease
  • Hydrocephalus
  • Central Nervous System Parenchymal Disease
  • Endocrine Disorders
  • Mass Lesions
  • Encephalopathy/vasculopathy
  • Seizures
  • Myelopathy
  • Peripheral Neuropathy
  • Myopathy
  • Clinical Course
  • Investigations
  • Differential Diagnosis
  • Laboratory Investigations
  • Establishing Systemic Sarcoidosis
  • Confirming Neurosarcoidosis
  • Neuroimaging
  • Epidemiology, Pathophysiology, and Genetics
  • Pathology
  • Management
  • Treatment
  • Peripheral Facial Nerve Palsy
  • Other Cranial Nerve Palsies and Aseptic meningitis
  • Hydrocephalus
  • Mass Lesion
  • Cns Parenchymal Disease
  • Seizures
  • Peripheral Neuropathy and Myopathy
  • Other Issues
  • Surgical Considerations
  • Alternative Treatments
  • Radiation Therapy
  • General Supportive Care
  • Conclusions
  • Chapter 22: Neurologic Complications of Lung Cancer
  • Introduction
  • Lung Cancer Metastases
  • Brain Metastases
  • Incidence
  • Clinical Features
  • Treatment
  • Spinal Epidural Metastases
  • Incidence and Clinical Features
  • Treatment
  • Spinal Intramedullary Metastases
  • Leptomeningeal Metastases
  • Skull Base and Dural Metastases
  • Pituitary Metastases
  • Brachial Plexus Metastases
  • Paraneoplastic Disorders
  • Overview
  • Autoimmunity
  • Clinical Syndromes
  • Multifocal Encephalomyelitis
  • Limbic Encephalitis
  • Cerebellar Degeneration
  • Opsoclonus-myoclonus
  • Extrapyramidal Syndrome
  • Brainstem Encephalitis
  • Optic Neuritis
  • Carcinoma-associated Retinopathy
  • Myelopathy
  • Stiff Person Syndrome
  • Motor Neuron Disease
  • Subacute Sensory Neuronopathy
  • Neuromyotonia
  • Other Neuropathies
  • Autonomic Insufficiency
  • Lambert-eaton Myasthenic Syndrome
  • Myopathies
  • Treatment and Outcomes
  • Section 3: Neurologic Aspects of Renal Diseases
  • Chapter 23: Neurologic Complications of Electrolyte Disturbances and acid-base Balance
  • Introduction
  • Hyponatremia
  • History and Terminology
  • Clinical Findings
  • Laboratory Investigations
  • Pathophysiology
  • Management
  • Hypernatremia
  • History and Terminology
  • Clinical Findings
  • Laboratory Investigations
  • Pathophysiology
  • Management
  • Hypokalemia
  • Terminology
  • Clinical Findings
  • Laboratory Investigations
  • Pathophysiology
  • Management
  • Hyperkalemia
  • Terminology
  • Clinical Findings
  • Laboratory Investigations
  • Management
  • Acid-Base Disorders
  • Terminology
  • Clinical Findings
  • Laboratory Investigations
  • Pathophysiology
  • Management
  • Other Electrolytic Disturbances
  • Hypocalcemia
  • Hypercalcemia
  • Hypomagnesemia
  • Hypermagnesemia
  • Hypophosphatemia
  • Hyperphosphatemia
  • Chapter 24: Neurologic Complications of Acute and Chronic Renal Disease
  • Introduction
  • Central Nervous System Complications
  • Uremic Encephalopathy
  • Acute Versus Chronic Uremic Encephalopathy
  • Pathogenesis
  • Diagnosis
  • Clinical Symptoms
  • Therapy
  • Central Nervous System Syndromes Associated with Renal Replacement Therapy
  • Dialysis Disequilibrium Syndrome
  • Pathogenesis
  • Clinical Presentation
  • Therapy
  • Wernickes Encephalopathy
  • Subdural Hematoma and Intracerebral Hemorrhage
  • Cognitive Impairment in Chronic Dialysis patients
  • Dialysis Encephalopathy Syndrome
  • Diagnosis
  • Clinical Symptoms
  • Treatment
  • Drug-induced Disorders in Renal Failure
  • Peripheral Nervous System Disorders
  • Uremic Polyneuropathy
  • Pathogenesis
  • Clinical Picture
  • Diagnosis
  • Therapy
  • Restless Legs Syndrome
  • Mononeuropathies
  • Autonomic Disturbances
  • Uremic Myopathy
  • Chapter 25: Nervous System Disorders in Dialysis Patients
  • Introduction
  • Central Nervous System Complications
  • Uremic Encephalopathy
  • Dialysis Disequilibrium Syndrome
  • Dialysis Dementia
  • Wernickes Encephalopathy
  • Posterior Reversible Leukoencephalopathy syndrome
  • Sleep Disorders
  • Restless Legs Syndrome
  • Dementia and Cognitive Impairment
  • Stroke
  • Increased Intracranial Pressure
  • Peripheral Nervous System Complications
  • Polyneuropathy
  • Mononeuropathies
  • Myopathy
  • Conclusion
  • Chapter 26: Nephrotic Syndrome
  • Background
  • Pathophysiology of Neurologic Sequelae
  • Hypercoagulability
  • Hyperlipidemia
  • Hypertension
  • Microalbuminuria
  • Infection and Systemic Disorders
  • Neurologic Manifestations
  • Cerebral Venous Thrombosis
  • Arterial Ischemic Stroke
  • Posterior Reversible Encephalopathy Syndrome
  • Guillain-Barré Syndrome
  • Myasthenia Gravis
  • Pituitary and Hormonal Disorders
  • Other Disorders
  • Diagnosis, Therapy, and Prognosis of Neurologic Aspects
  • Conclusion
  • Chapter 27: Use of Antiepileptic Drugs in Hepatic and Renal Disease
  • Introduction
  • Individual Antiepileptic Drugs
  • Phenytoin
  • Valproic Acid
  • Phenobarbital
  • Primidone
  • Carbamazepine, Oxcarbazepine, and eslicarbazepine
  • Carbamazepine
  • Oxcarbazepine
  • Eslicarbazepine Acetate
  • Lamotrigine
  • Levetiracetam
  • Topiramate
  • Lacosamide
  • Tiagabine
  • Gabapentin and Pregabalin
  • Vigabatrin
  • Zonisamide
  • Felbamate
  • Ethosuximide
  • Rufinamide
  • Ezogabine/retigabine
  • Conclusions
  • Section 4: Neurologic Aspects of Rheumatologic/musculoskeletal Diseases
  • Chapter 28: Neurologic Complications of Craniovertebral Dislocation
  • Introduction
  • Historical Background
  • Anatomic Concepts
  • Clinical Features of Craniovertebral Subluxation
  • Progressive Craniovertebral Subluxation
  • Traumatic Craniovertebral Subluxation
  • Neuroimaging
  • Craniovertebral Subluxations Associated with Neurologic Complications
  • Rheumatoid Arthritis and Other Inflammatory Joint Disorders
  • Grisels Syndrome
  • Down Syndrome
  • Craniovertebral Abnormalities in Metabolic bone Disease
  • Pagets Disease
  • Osteomalacia
  • Osteogenesis Imperfecta
  • Hadju-Cheney Syndrome and Spondyloepiphsyeal Dysplasia
  • Achondroplasia
  • Mucopolysaccharidosis
  • Congenital Malformations of the Craniovertebral Junction
  • Additional Craniovertebral Disorders
  • Acknowledgments
  • Chapter 29: Rheumatoid Arthritis, Spondyloarthropathies, and relapsing polychondritis
  • Rheumatoid Arthritis
  • Introduction
  • Subclinical Neurologic Disease
  • Nerve Entrapment
  • Vasculitic Neuropathy
  • Leptomeningeal Involvement
  • Cerebral Vasculitis
  • Autonomic Dysfunction
  • Management
  • Atlantoaxial Subluxation
  • Neurologic Complications of Treatment For rheumatoid Arthritis
  • Prognosis
  • Conclusion
  • Inflammatory Spondyloarthropathies
  • Clinical Features
  • Pathogenesis
  • Laboratory Investigations
  • Neurologic Aspects of the Spondyloarthropathies
  • Acute Spinal Fractures
  • Discovertebral Destruction
  • Cauda Equina Syndrome
  • Miscellaneous Neurologic Aspects of Spondyloarthropathies
  • Relapsing Polychondritis
  • Clinical Findings
  • Natural History
  • Diagnosis
  • Pathogenesis and Treatment
  • Chapter 30: Connective Tissue Disorders: Systemic Lupus Erythematosus, Sjögrens Syndrome, and Scleroderma
  • Introduction
  • Systemic Lupus Erythematosus
  • Incidence
  • Neuropsychiatric Manifestations in Systemic lupus Erythematosus
  • Cognitive Dysfunction
  • Headache
  • Psychosis, Mood Changes, and Anxiety
  • Seizures
  • Cerebrovascular Disease
  • Demyelinating Lesions
  • Peripheral Nervous System Disorders
  • Neurologic Presentations of the Antiphospholipid Syndrome
  • Pathogenesis of Neuropsychiatric Lupus
  • Diagnosis of Neuropsychiatric Lupus
  • Management
  • Scleroderma (systemic Sclerosis)
  • Neurologic Complications
  • Musculoskeletal Involvement
  • Peripheral Nervous System Involvement
  • Central Nervous System Involvement
  • Autonomic Involvement
  • Treatment
  • Sjgren's Syndrome
  • Neurologic Complications
  • Central Nervous System Involvement
  • Peripheral Nervous System Involvement
  • Muscle Involvement
  • Autonomic Involvement
  • Treatment
  • Chapter 31: Cerebral Vasculitis
  • Introduction and General Comments
  • Cerebral Vasculitis of Infectious origin
  • Noninfectious, Inlammatory, Giant Cell, or Nectrotizing Vasculitis
  • Giant Cell Vasculitis
  • Takayasu Disease
  • Giant Cell Arteritis
  • Necrotizing Vasculitis
  • Polyarteritis Nodosa
  • Cogan Syndrome
  • Wegener Disease
  • Churg-Strauss Angiitis
  • Microscopic Polyangiitis
  • Primary Angiitis of the Central Nervous System
  • Amyloid-beta-related Angiitis
  • Buerger Disease
  • Chapter 32: Idiopathic Inflammatory Myopathies
  • History (including Classification)
  • Epidemiology
  • Etiopathogenesis
  • Clinical Features
  • Natural History
  • Laboratory Investigations
  • Serum CK Activity
  • Autoantibodies
  • Electromyography
  • Skin Biopsy
  • Muscle Biopsy
  • Neuroimaging Investigations
  • Management
  • Corticosteroids
  • Second-line Treatment
  • Future Therapeutic Prospects
  • Chapter 33: Fibromyalgia
  • History
  • Clinical Findings
  • Clinical Presentation
  • Diagnostic Criteria
  • Natural History
  • Epidemiology
  • Course of Fibromyalgia
  • Laboratory Investigations
  • Neuroimaging Investigations
  • Single-photon Emission Computed Tomographic Imaging
  • Functional Magnetic Resonance Imaging
  • Positron Emission Tomographic Imaging
  • Proton Magnetic Resonance Spectroscopy
  • Genetic Influences
  • Pathophysiology
  • Peripheral Influences
  • Central Nervous System
  • Central Sensitization
  • Diffuse Noxious Inhibitory Control
  • Dopamine
  • Glia
  • Endocrine Influences
  • Hypothalamic-pituitary-adrenal Axis
  • Growth Hormone
  • Prenatal Stress Influence
  • Autonomic Dysautonomia
  • Other
  • Management
  • Nonpharmacologic Management
  • Education
  • Cognitive Behavioral Therapy
  • Exercise
  • Multidisciplinary Therapy
  • Pharmacologic Management
  • Antidepressants
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin-norepinephrine Reuptake Inhibitors
  • a2-delta Ligands
  • Opioids
  • Tramadol
  • Dopamine Agonists
  • Sedatives
  • Serotonin 5-HT3 Receptor Antagonists
  • Cannabinoids
  • Complementary Treatment
  • Acupuncture
  • Vitamin D
  • Conclusions
  • Chapter 34: Pagets Disease of Bone
  • History
  • Clinical Findings
  • Natural History
  • Laboratory Investigations
  • Neuroimaging Investigations
  • Genetics
  • Pathology
  • Management
  • Conclusions
  • Chapter 35: Spinal Stenosis
  • Definition of Spinal Stenosis
  • History
  • Classification
  • Epidemiology
  • Pathophysiology
  • Narrowing and Stenosis
  • Claudication
  • Neurogenic Compression Theory
  • Vascular Compression Theory
  • Myelopathy
  • Diagnosis
  • Symptoms
  • Physical Examination
  • Ancillary Tests
  • Radiographs and Myelography
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Neurophysiology
  • Additional Diagnostics
  • Differential Diagnosis
  • Management
  • Nonoperative Management
  • Operative Management
  • Outcome
  • Conclusions
  • Chapter 35: Neurologic Manifestations of Achondroplasia
  • Introduction
  • Complications Associated with Achondroplasia
  • Macrocephaly and Hydrocephalus
  • Craniocervical Junction Anomalies
  • Sudden Death in Children
  • Sudden Death in Adults
  • Sleep Apnea Syndrome
  • Disorders of Respiration
  • Myelopathy
  • Syringobulbia-myelia
  • Developmental Delay
  • Vertebral Canal Stenosis
  • Vertebral Column Malalignment
  • Nerve Root Compression
  • Homozygous Achondroplasia
  • Management of Achondroplasia
  • Acknowledgments
  • Chapter 36: Neurologic Manifestations of Inherited Disorders of connective tissue
  • Introduction
  • Neurologic Manifestations of the most Common Inherited disorders of connective Tissue
  • Vascular Ehlers-Danlos Syndrome
  • General Description
  • Neurologic Complications
  • Carotid-cavernous Fistula
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Cervical Artery Dissection
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Intracranial Hemorrhage and Intracranial Aneurysms
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Marfan Syndrome
  • General Description
  • Neurologic Complications
  • Cerebral and Spinal Cord Ischemia
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Hemorrhagic Complications
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Other Neurologic Complications
  • Ehlers-Danlos Syndromes Other than the Vascular Type
  • General Description
  • Neurologic Complications
  • Cerebrovascular Complications
  • Other Neurologic Complications
  • Peripheral Nerve and Muscle Complications
  • Central Nervous System Complications
  • Other
  • Loeys-Dietz Syndrome
  • General Description
  • Neurologic Complications
  • Cerebrovascular Complications
  • Other Neurologic Complications
  • Arterial Tortuosity Syndrome
  • General Description
  • Neurologic Complications
  • Pseudoxanthoma Elasticum
  • General Description
  • Neurologic Complications
  • Cerebrovascular Complications
  • Homocystinuria
  • General Description
  • Neurologic Complications
  • Cerebrovascular Complications
  • Mechanisms and Frequency
  • Clinical Characteristics and Management
  • Other Neurologic Complications
  • Osteogenesis Imperfecta
  • General Description
  • Neurologic Complications
  • Cerebrovascular Complications
  • Other Neurologic Complications
  • Mucopolysaccharidoses
  • General Description
  • Neurologic Complications
  • Conclusions
  • Chapter 38: Nonsteroidal anti-inflammatory Drugs Exposure and the central nervous System
  • Introduction
  • Aseptic Meningitis
  • Nsaids and the Risk of Stroke
  • Nsaids and Neuronal Degeneration
  • Medication Overuse Headache
  • Reye's Syndrome
  • Other Nsaid Adverse Effects
  • Overdose and Intoxication
  • Summary
  • Index

Contributors


H.P. Adams, Jr.,     Division of Cerebrovascular Diseases, Department of Neurology, Carver College of Medicine, University of Iowa Health Care Stroke Center, University of Iowa, Iowa City, IA, USA

J.L. Antunes,     Department of Neurosurgery, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal

J.J. Asconapé,     Department of Neurology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA

H. Attarian,     Circadian Rhythms and Sleep Research Laboratory, Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

E. Auriel,     Department of Neurology, Tel-Aviv University, Ramat-Aviv, Israel

S. Bansal,     Pediatric Neurology, National Children’s Medical Center, Washington, DC, USA

V.K. Bansal,     Division of Nephrology and Hypertension, Loyola University Medical Center, Maywood, IL, USA

C.L. Bassetti,     Department of Neurology, University Hospital of Bern (Inselspital), Bern, Switzerland

P. Berlit,     Department of Neurology and Clinical Neurophysiology, Alfried-Krupp-Hospital, Essen, Germany

J. Biller,     Department of Neurology, Loyola University Medical Center, Maywood, IL, USA

M.W. Baumgaertel,     St. Franziskus Hospital Muenster, Department of Nephrology, Münster, Germany

J.B. Bodensteiner,     Department of Neurology, Mayo Clinic, Rochester, MN, USA

I.J. Butler,     Division of Child and Adolescent Neurology, Department of Pediatrics, University of Texas Medical School, Houston, TX, USA

P. Camacho,     Loyola University Osteoporosis and Metabolic Bone Disease Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA

L.R. Caplan,     Division of Stroke and Cerebrovascular Disease, Beth Israel Deaconess Medical Center, Boston, MA, USA

J.S. Cho,     Division of Vascular Surgery and Endovascular Therapy, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA

S. Cruz-Flores,     Department of Neurology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA

M. de Carvalho,     Department of Neurosciences, St Maria Hospital, and Institute of Molecular Medicine, Lisbon, Portugal

E. de los Reyes,     Division of Child Neurology, Ohio State University, Columbus, OH, USA

M. de Visser,     Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands

S. Debette,     Department of Epidemiology and Public Health, Raymond Poincaré Hospital, Garches; INSERM Unit U708, Pitié-Salpêtriѐre Hospital, Paris and University of Versailles – St Quentin en Yvelines, Versailles, France

R.S. Dieter,     Division of Cardiology, Department of Medicine, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, USA

K. Dombrowski,     Department of Medicine (Neurology), Duke University Medical Center, Durham, NC, USA

E.J. Dropcho,     Department of Neurology, Indiana University Medical Center, Indianapolis, IN, USA

A.J. Espay,     James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, UC Neuroscience Institute, University of Cincinnati, Cincinnati, OH, USA

J.M. Ferro,     Department of Neurosciences, Serviço de Neurologia, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal

A.C. Fonseca,     Department of Neurosciences, Serviço de Neurologia, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal

A.F. Francisco,     Department of Neurosurgery, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal

D.P. Germain,     Division of Medical Genetics, National Referral Center for Fabry disease and Inherited Disorders of Connective Tissue, CHU Raymond Poincaré, Garches and University of Versailles – St Quentin en Yvelines, Versailles, France

G. Gruener,     Leischner Institute of Medical Education and Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA

M.N. Haque,     Division of Cardiology, Department of Medicine, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, USA

J.T. Hecht,     Department of Pediatrics and Pediatric Research Center, University of Texas Medical School, Houston, TX, USA

R. Hershberger,     Division of Vascular Surgery and Endovascular Therapy, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA

S. Hocker,     Division of Critical Care Neurology, Mayo Clinic, Rochester, MN, USA

S.E. Kasner,     Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA

C.S. Kidwell,     Department of Neurology, Georgetown University Medical Center, Washington, DC, USA

A.D. Korczyn,     Department of Neurology, Tel-Aviv University, Ramat-Aviv, Israel

M. Kraemer,     Department of Neurology and Clinical Neurophysiology, Alfried-Krupp-Hospital, Essen, Germany

A. Krumholz,     Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA

D. Laskowitz,     Departments of Medicine (Neurology), and Anesthesiology, Duke University Medical Center, Durham, NC, USA

M.C. Leary,     Department of Neurology, Harvard Clinical Research Institute, Boston, MA, USA

D.S. Liebeskind,     UCLA Stroke Center, Los Angeles, CA, USA

M. McCoyd,     Department of Neurology, Loyola University Healthcare Center, Maywood, IL, USA

T. McKiernan,     Center for Heart and Vascular Medicine, Loyola University Healthcare Center, Maywood, IL, USA

J.L. Melancia,     Department of Neurosurgery, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal

Y. Molad,     Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv and Rheumatology Unit, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel

J.F. Moran,     Division of Cardiology, Loyola University Medical Center, Maywood, IL, USA

D.E. Moulin,     Departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario

J. Mukherji,     Department of Anesthesiology, Loyola University Medical Center, Maywood, IL, USA

S. Oana,     Department of Anesthesiology, Loyola University Medical Center, Maywood, IL, USA

R.A. Ostrowski,     Division of Rheumatology, Department of Medicine, Loyola University Medical Center, Maywood, IL, USA

T....

Dateiformat: EPUB
Kopierschutz: Adobe-DRM (Digital Rights Management)

Systemvoraussetzungen:

Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).

Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions (siehe E-Book Hilfe).

E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat EPUB ist sehr gut für Romane und Sachbücher geeignet - also für "fließenden" Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an. Mit Adobe-DRM wird hier ein "harter" Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.

Weitere Informationen finden Sie in unserer E-Book Hilfe.


Download (sofort verfügbar)

202,30 €
inkl. 19% MwSt.
Download / Einzel-Lizenz
ePUB mit Adobe DRM
siehe Systemvoraussetzungen
E-Book bestellen

Unsere Web-Seiten verwenden Cookies. Mit der Nutzung dieser Web-Seiten erklären Sie sich damit einverstanden. Mehr Informationen finden Sie in unserem Datenschutzhinweis. Ok